Last reviewed · How we verify

NCT05190497

Effects of IMT on Pulmonary Functions IN CASES With Inhalation Injury

Status unknown NA Last updated 13 January 2022
What this trial tests

NA trial testing Exercise group in Inhalation Injury in 40 participants. Status unknown.

Timeline
30 November 2021
Primary endpoint
15 February 2022
28 February 2022

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date30 November 2021
Primary completion15 February 2022
Estimated completion28 February 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 35, any sex, with Inhalation Injury or Pulmonary Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aimed to investigate the effect of inspiratory muscle training (IMT) on pulmonary functions (FEV1and FVC), and respiratory muscle strength in patients with inhalation injury, which may prove to be a promising intervention helping to improve exercise tolerance, relieve dyspnea and suggests an improvement in respiratory muscle function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise group

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05190497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing